Today, May 1st, marks the 10-year anniversary of the first commercial HeRO Graft (Hemodialysis Reliable Outflow) implantation performed by John R. Ross, MD, founding physician1, lead surgeon, and medical director2 of the Dialysis Access Institute at the Regional Medical Center in Orangeburg, SC.
Designed for high-risk patients with end-stage renal disease, the HeRO Graft bypasses central venous stenosis, creating a pathway for blood to move to the heart. According to Dr. Ross, these patients typically have had multiple accesses and a lengthy total catheter contact time.
“Many of the patients that we’re putting HeROs in now really only have one other option and that’s to have a long-term catheter, which has a far greater mortality and morbidity than having a running-blood access,” explains Dr. Ross. “This is where the HeRO fits in.” 3
Living up to its name for the past decade, the HeRO has been implanted worldwide, offering access-challenged patients who have exhausted all other access options the chance to continue life-saving hemodialysis. Merit Medical recently sat down with Dr. Ross to reflect on the first HeRO Graft implant and the impact this innovation has had on patient care. Watch the above video.